Physician profile
Alexander Neuwirth
NPI 1538429824
$31,997.48
in general payments reported to CMS, 2019-2025
10 companies · $6,991 in 2025
The $6,991 reported for 2025 was more than what 85% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,150 · 2020: $316 · 2021: $972 · 2022: $3,772 · 2023: $5,183 · 2024: $6,614 · 2025: $6,991.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Food and Beverage: $4,228 · Travel and Lodging: $625.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,935.00 |
| Food and Beverage | $4,227.87 |
| Travel and Lodging | $625.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $15,520.44 | 2019-2025 | Journey II, K-15 Pork, Real Intelligence |
| Medical Device Business Services, INC. | $8,921.83 | 2022-2025 | Attune, Velys, Actis |
| Zimmer Biomet Holdings, INC. | $3,289.68 | 2019-2025 | Persona, Avenir, Rosa |
| Depuy Synthes Sales INC. | $2,317.62 | 2019-2024 | Actis, Attune, Velys |
| Stryker Corporation | $1,011.13 | 2019-2024 | Mako |
| Medtronic, INC. | $299.16 | 2023-2025 | Cd Horizon Spinal System, Unid_pass |
| Linkbio Corp | $285.51 | 2021 | |
| Novastep INC. | $149.57 | 2023 | Peca Bunion Correction System |
| Horizon Therapeutics Plc | $141.73 | 2019 | |
| Ethicon US, LLC | $60.81 | 2025 | Stratafix, Ethicon, Surgicel Nu-Knit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Neuwirth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.